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heart failure and renal failure impair physical and 
mental activities, thereby reducing social productivity. 
These cardiovascular diseases and organ dysfunctions 
occur based on the development of arteriosclerosis 
which is promoted by aging, smoking and lifestyle-
related diseases such as hypertension, diabetes melli-
tus and dyslipidemia. Among these risk factors of car-
diovascular diseases, hypertension exerts major effects 
on the development of arteriosclerosis and the inci-
dence of cardiovascular diseases. Therefore, the anti-
hypertensive therapy is of utmost importance to 
inhibit the incidence of cardiovascular diseases and 
????????????
Cardiovascular diseases such as stroke and coro-
nary artery disease are the major cause of death 
worldwide alongside cancers and infectious diseases. 
In addition, cardiovascular organ failures such as 
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???????
In order to prevent cardiovascular events and organ injuries in hypertensive patients, strict blood pres-
sure（BP）control over 24 hours is of utmost importance. In addition to the BP level, it has been indicated 
that the variabilities of blood pressure during a day or between visits also influence the risk of cardiovas-
cular disorders. This study aimed to delineate the factors relating to the variations of office and home BPs 
throughout a year in hypertensive outpatients under antihypertensive therapy. The office BP value
（131/77 mmHg）was comparable to the morning home BP（130/76）, but was higher compared to the eve-
ning home BP（126/73）, however, the coefficient of variation（CV）values were comparable between the 
office and the home BPs. Correlations of BP and CV were stronger between the morning and the evening 
home BPs than between the office and the home BPs. The CV of systolic office BP was greater in patients 
with diabetes mellitus than the patients without diabetes（7.8 vs 6.1％）. In patients with chronic kidney 
disease, the CVs of diastolic office BP and evening home BP were greater than the patients without chron-
ic kidney disease（8.0 vs 6.2％ and 8.1 vs 6.7％, respectively）. In addition, The CVs of diastolic morning 
and evening home BP were positively correlated with serum creatinine and a negatively correlated with 
estimated glomerular filtration rate. Patients with cardiovascular diseases such as stroke and coronary 
artery disease showed greater CV of diastolic morning home BP than the patients without cardiovascular 
diseases（8.2 vs 6.6％）. These results suggest that the home BP exhibits different variability from the office 
BP, and the BP variability is increased in high-risk hypertensive patients with diabetes mellitus, chronic 
kidney disease or cardiovascular diseases.
?????????：hypertension, home blood pressure, blood pressure variation
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organ failures in hypertensive patients. In fact, accord-
ing to the meta-analysis of clinical studies, 10 mmHg 
lowering of systolic blood pressure（BP）is associated 
with 30-40％ reduction in stroke and 20-30％ reduc-
tion in coronary artery disease 1,2）.
Hypertension is generally defined as BP levels of 
140/90 mmHg or higher. Meta-analysis of epidemio-
logical studies shows lower systolic and diastolic BP 
levels are associated with lower risk of cardiovascular 
diseases such as stroke and ischemic heart diseases in 
wide range of age strata, and this relationship can be 
observed even in the normotensive range below 
140/90 mmHg to the level as low as 115/75 mmHg3）. 
In the clinical practice, antihypertensive therapy is 
generally performed based on the office BP values, 
however, the out-of-office BPs such as ambulatory BP 
and home BP have been shown to be more predictive 
of the incidence of cardiovascular diseases and cardio-
vascular organ injuries than office BP. Furthermore, it 
has been reported that other than BP values, the vari-
abilities of BP such as diurnal changes and visit-to-
visit variations are associated with the risk of develop-
ing cardiovascular diseases and organ injuries 4,5）. In 
this respect, it seems there is insufficient information 
indicating the day-to-day variation of home BP and 
its relations to the cardiovascular disorders.
In this study, the variations of office and home BPs 
throughout the year were evaluated in hypertensive 
out-patients under antihypertensive treatment, and 
the factors relating to these BP variations were ana-
lyzed.
???????
In this study, 83 hypertensive out-patient subjets 
who recorded their home blood pressure measure-
ments were enrolled. We excluded any patients with 
poorly controlled hypertension which exceeded 
160/100 mmHg or there was a secondary cause of 
hypertension other than chronic kidney disease
（CKD）. However, patients undergoing renal replace-
ment therapy were not included in this study. In addi-
tion, we excluded any patients who developed cardio-
vascular events during the year BP data were 
collected or any patients who had poor adherence to 
antihypertensive medication.
BP records were collected during the year of 2016
（57 patients）and 2017（26 patients）in which the pre-
scriptions of antihypertensive drugs were not 
changed. Office BP was measured with a sphygmoma-
nometer for 1-2 times in the sitting position after 
resting for at least 20 min at each visit every 4 to 8 
weeks. The average value was calculated and used 
for the analyses whenever the office BP was mea-
sured twice during visits. The average number of vis-
its was 8.2 times per year. Home BP was measured 
every day using an arm-cuff oscillometric automatic 
manometer within 1 hour of awakening（before taking 
drugs）as morning blood pressure and before going to 
bed as evening blood pressure. All the home BP 
records within 7 days before each visit were collected 
for the analyses. The home BP was also measured 
1-2 times and the average value was recorded when-
ever the measurement was repeated twice. The 
patients used their own manometers equipped with 
arm cuffs. The data of office BP and home BP were 
collected from all 83 participants. In addition to calcu-
lating the average value of office BP, the coefficient of 
variation（CV）was calculated as percent value of the 
standard deviation（SD）to the mean. The average 
and CV were also calculated for morning and evening 
home BP.
Blood samples were obtained after overnight fasting 
during the year in which blood pressure data were 
recorded. The samples were served for the measure-
ments of blood cell counts and routine blood chemis-
try including liver enzymes, total protein, albumin, 
renal function, uric acid, electrolytes, lipids, glucose 
and hemoglobin A1c. Serum LDL cholesterol was cal-
culated by the Friedewald’s formula 6）：LDL cholester-
ol＝total cholesterol−HDL cholesterol−（triglycerides
×0 .2）. The estimated glomerular filtration rate
（eGFR）was calculated from the serum creatinine 
level and age by the following equation 7）：eGFR＝194
×Age−0.287×sCr−1.094（×0.739 for females）. Casual 
urine samples were also collected during the year for 
the evaluation of proteinuria.
The study protocol was in accordance with the rec-
ommendations of the World Medical Association for 
biomedical research involving human subjects and 
was approved by the institutional review board. 
Informed consent was obtained from all subjects after 
explaining the study objective and design.
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Clinical data were expressed as means±standard 
deviations（SD）. Values between the 2 groups were 
compared by t-test, however, Wilcoxon test was 
applied for the data with skewed distribution. Com-
parisons of 3 groups were performed using analysis of 
variance（ANOVA）followed by Dunnett’s t-test for 
post-hoc between group comparisons. Correlations 
between the two variables were analyzed by linear 
regression analysis. A P value of less than 0.05 was 
considered to be statistically significant.
???????
The background characteristics of study subjects 
are shown in Table 1. Lifestyle related diseases other 
than hypertension such as diabetes mellitus, dyslipid-
emia and hyperuricemia are complications in 27.7％, 
44 .6％ and 34 .9％ of the patients, respectively. In 
addition, 24 patients have complications with cardio-
vascular diseases（CVD）such as cerebrovascular dis-
ease（n＝3）, coronary artery disease（n＝11）, valvular 
heart disease（n＝2）, arrhythmia（n＝8）and peripher-
al artery disease（n＝3）. Three patients had two car-
diovascular diseases. Forty-eight patients correspond-
ed to CKD def ined as eGFR less than 6 0 mL/
min/1.73 m2 or proteinuria. The causes of CKD were 
diabetic nephropathy（n＝16）, chronic glomerulone-
phritis（n＝15）, nephrosclerosis（n＝14）, chronic 
pyelonephritis（n＝1）, lupus nephritis（n＝1）and 
drug-induced nephropathy（n＝1）.
Table 2 shows the drugs given to the patients. As 
an antihypertensive medication, calcium channel 
blockers（CCB）and angiotensin II receptor blockers
（ARB）were most frequently used. These antihyper-
tensive medications were not changed during the 
year in which the office and home blood pressure data 
were collected. In addition, drugs for lifestyle-related 
diseases were administered to respective patients 
with diabetes mellitus. dyslipidemia and hyperurice-
mia.
The laboratory findings of study subjects were list-
ed in Table 3 . Although some of the patients had 
complication with diabetes mellitus, dyslipidemia and 
hyperuricemia, they were treated with respective 
medications indicated in Table 2 and the average val-
ues of blood glucose, hemoglobin A1c, serum lipids 
and uric acid were in the normal ranges. Among the 
48 patients with CKD, 46 showed eGFR less than 
60 mL/min/1.73 m2 and 27 showed proteinuria. There-
fore, the averaged serum creatinine was higher and 
the averaged eGFR was lower than the normal range 
in the total study subjects.
Table 4 shows the average values and CV of office 
and home BP and heart rate（HR）. Average systolic 
and diastolic office BPs were comparable to morning 
home BP but were higher compared to the evening 
home BP（p＝0.011 for systolic BP and p＝0.005 for 
diastolic BP）. Accordingly, systolic and diastolic values 
of morning home BP were higher than those of eve-
???????　 Background characteristics of the study 
subjects
Age, years 68.3±10.5
Gender, male/female 34/49
Body mass index, kg/m2 22.3±3.7
Complications
　Diabetes mellitus 23（27.7％）
　Dyslipidemia 37（44.6％）
　Hyperuricemia 29（34.9％）
　Cardiovascular disease 24（28.9％）
　Chronic kidney disease 48（57.8％）
Data are the mean±SD.
???????　 Antihypertensive medications and other drugs given 
in the 83 patients
Drug Number of patients Percentage
Antihypertensive drug
　Diuretic 13 15.7％
　b  blocker 11 13.3％
　Calcium channel blocker 56 67.5％
　ARB 61 73.5％
　ACEI 3 3.6％
　Other 16 19.3％
Anti-diabetic drug 16 19.3％
Lipid-lowering drug 37 44.6％
Antihyperuricemic drug 15 18.1％
Anti-anginal drug 9 10.8％
Anti-platelet drug 20 24.1％
ARB：angiotensin II receptor blocker, ACEI：angiotensin con-
verting enzyme inhibitor.
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ning home BP（p＝0.017 and p＝0.035, respectively）. 
As for CV, significant differences were not observed 
among the office and the home BPs.
Table 5 shows the correlations between office and 
home measurements of BP and HR. Either systolic or 
diastolic BP, the correlations were closer between the 
morning and the evening home BPs than between the 
office BP and the morning or the evening home BP. 
Also the correlations of HR values were closer 
between the morning and the evening home measure-
ments than between the office and the home measure-
ments. With regards to the correlations of CV values 
between the office and the home measurements, as 
shown in Table 6, the CV of systolic office BP did not 
have significant correlation with the CV of morning or 
evening home systolic BP. The correlation of CV of 
HR was also closer between the morning and the eve-
ning home measurements than between the office and 
the home measurements.
Figure 1A depicts the office and the home BPs 
between patients with or without diabetes mellitus. 
The diabetic patients had lower diastolic office BP 
than the non-diabetic patients, however, the diastolic 
home BP in the morning or evening did not differ 
???????　Laboratory data of the study subjects
Blood chemistry Blood cell count
AST, U/L
ALT, U/L
Total protein, g/dL
Albumin, g/dL
Uric acid, mg/dL
Creatinine, mg/dL
eGFR, mL/min/1.73 m2
Glucose, mg/dL
Hemoglobin A1c, ％
HDL cholesterol, mg/dL
LDL cholesterol, mg/dL
Triglycerides, mg/dL
22±6
18±8
7.1±0.5
4.1±0.3
5.7±1.4
1.28±1.10
54.5±25.5
105±21
5.9±0.5
60±16
117±30
139±73
WBC, ×10 3/mm3
RBC, ×10 4/mm3
Hemoglobin, g/dL
Hematocrit, ％
Platelet, ×10 4/mm3
6.26±2.02
427±57
12.8±1.6
39.3±4.6
24.7±7.1
Urinalysis
Proteinuria, ＋/− 27/56
Mean±SD. AST：aspartate transaminase, ALT：alanine transaminase, eGFR：
estimated glomerular filtration rate, HDL：high-density lipoprotein, LDL：low-
density lipoprotein, WBC：white blood cell, RBC：red blood cell.
???????　 Average values and coefficient of variations of office blood pressure 
and morning and evening home blood pressure
Average value Coefficient of variation, ％
Office blood pressure
　Systolic, mmHg 130.7±12.5 7.2±2.6
　Diastolic, mmHg 76.9±9.2 7.4±2.8
　Heart rate, bpm 72.0±10.3 7.3±2.9
Morning home blood pressure
　Systolic, mmHg 130.4±10.2 6.1±2.1
　Diastolic, mmHg 76.0±8.9 7.0±2.8
　Heart rate, bpm 69.1±9.6 7.3±3.6
Evening home blood pressure
　Systolic, mmHg 126.1±10.0 6.5±2.2
　Diastolic, mmHg 73.0±8.2 7.7±2.8
　Heart rate, bpm 70.2±9.4 7.2±2.6
Mean±SD.
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???????　Correlations between the averaged values of blood pressure and heart rate
Office-Morning Office-Evening Morning-Evening
r P value r P value r P value
Systolic BP 0.333 　0.0022 0.352 　0.0022 0.818 ＜0.0001
Diastolic BP 0.548 ＜0.0001 0.492 ＜0.0001 0.879 ＜0.0001
Heart rate 0.762 ＜0.0001 0.752 ＜0.0001 0.914 ＜0.0001
BP：blood pressure, r：correlation coefficient.
???????　 Correlations between the coefficient of variation of blood pressure and heart 
rate values
Office-Morning Office-Evening Morning-Evening
r P value r P value r P value
Systolic BPV 0.217 0.0504 0.087 0.4653 0.619 ＜0.0001
Diastolic BPV 0.354 0.0011 0.233 0.0489 0.552 ＜0.0001
HRV 0.250 0.0339 0.168 0.1787 0.528 ＜0.0001
BPV：blood pressure variation, HRV：heart rate variation, r：correlation coefficient.
????????
Average values（?）and coefficient of variations（?）of office and home blood pressures 
in patients with or without diabetes mellitus（DM）. SBP：systolic blood pressure, 
DBP：diastolic blood pressure.
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between the diabetic and the non-diabetic patients. 
The CVs of office and home BPs were compared 
between diabetic and nondiabetic patients in Figure 
2B. The CV of office systolic BP was larger in the dia-
betic patients than that in the nondiabetic patients. 
On the other hand, the CVs of morning and evening 
home BPs did not significantly differ between the dia-
betic and the non diabetic patients.
Figure 2A and 2B displays the office and the home 
BPs and their CVs in patients with or without CKD. 
The office BPs were not significantly different 
between the two groups, however, the evening home 
systolic BP was higher in the CKD patients than in 
the nonCKD patients. As for the CV of BP, The CVs 
of office diastolic BP and evening home diastolic BP 
were higher in CKD than that in nonCKD.
Office and home BPs and their CVs in patients with 
CVD were compared in Figure 3A and 3B, respec-
tively. Although the systolic and diastolic office BPs 
were lower in the CVD patients than in the nonCVD 
patients, the morning and the evening home BPs 
were not significantly different between the CVD and 
the nonCVD patients. On the other hand, the CV of 
diastolic morning home BP was larger in the CVD 
patients than that in the nonCVD patients, while the 
CVs of systolic and diastolic office BPs did not signifi-
cantly differ between CVD and nonCVD.
Table 7 displays the correlations of office and home 
BP with the indices of renal function. The morning 
and evening home systolic BPs showed positive corre-
lations with serum creatinine and a negative correla-
tions with eGFR, while such correlations were not 
observed between the office BP and renal function
（Figure 4）. Table 8 displays the correlations of CVs of 
????????
Average values（?）and coefficient of variations（?）of office and home blood pressures in 
patients with or without chronic kidney disease（CKD）. SBP：systolic blood pressure, 
DBP：diastolic blood pressure.
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???????　 Correlations between coefficient of variation of 
blood pressure and indices of renal function
Serum creatinine eGFR
r P value r P value
Office BP
　Systolic BP −0.008 0.944 　0.004 0.969
　Diastolic BP 　0.048 0.666 −0.052 0.641
Morning home BP
　Systolic BP 　0.174 0.117 −0.058 0.605
　Diastolic BP 　0.302 0.005 −0.223 0.047
Evening home BP
　Systolic BP 　0.210 0.057 −0.134 0.257
　Diastolic BP 　0.345 0.003 −0.249 0.034
eGFR：estimated glomerular filtration rate, BP：blood 
pressure, r：correlation coefficient.
???????　 Correlations between blood pressure values and 
indices of renal function
Serum creatinine eGFR
r P value r P value
Office BP
　Systolic BP 　0.201 0.0679 −0.190 0.0847
　Diastolic BP −0.106 0.3403 　0.165 0.1362
Morning home BP
　Systolic BP 　0.267 0.0155 −0.284 0.0098
　Diastolic BP −0.173 0.1206 　0.140 0.2096
Evening home BP
　Systolic BP 　0.274 0.0191 −0.297 0.0108
　Diastolic BP −0.181 0.1251 　0.109 0.3571
eGFR：estimated glomerular filtration rate, BP：blood 
pressure, r：correlation coefficient.
????????
Average values（?）and coefficient of variations（?）of office and home blood pressures in 
patients with or without cardiovascular diseases（CVD）. SBP：systolic blood pressure, 
DBP：diastolic blood pressure.
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????????
Correlations between average home blood pressure and indices of renal function. SBP：systolic blood pressure, 
eGFR：estimated glomerular filtration rate.
????????
Correlations between average home blood pressure variability and indices of renal function. CV：coefficient of 
variation, DBP：diastolic blood pressure, eGFR：estimated glomerular filtration rate.
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office and home BP with the renal function indices. 
The CVs of morning and evening home diastolic BP 
showed positive correlations with serum creatinine 
and a negative correlations with eGFR, while such 
correlations were not observed between the CV of 
office BP and renal function（Figure 5）.
??????????
Large number of hypertensive patients enrolled in 
this study had cardiovascular risk factors such as dia-
betes mellitus and dyslipidemia and had complications 
with CVD and CKD. It is recognized that CKD 
patients have increased risk of cardiovascular diseases 
as well as the risk of falling into renal failure requir-
ing renal replacement therapy. Therefore, the large 
part of patients involved in this study are thought to 
be at high risk for developing cardiovascular diseases. 
In high-risk hypertensive patients with diabetes melli-
tus and or CKD presenting proteinuria, the strict tar-
get BP level of less than 130/80 mmHg is recom-
mended 8）. In addition, it is important to control not 
only the office BP but also the out-of-office BP such 
as ambulatory BP and home BP in order to prevent 
cardiovascular disorders sufficiently because, the lat-
ter is more intimately associated to the cardiovascular 
risk. Therefore, it is recommended to take priority in 
the home BP over the office BP for evaluating and 
controlling the BP of hypertensive patients 9,10）.
BP is an always varying index of cardiovascular 
hemodynamics. The variability of BP is evaluated in 
wide range of time phase from seconds to years. The 
shortest time phase of BP variation is the beat-to-
beat BP variation which is subject to the baroreceptor 
function and the activities of sympathetic and para-
sympathetic nerve system. This beat-to-beat varia-
tion of BP has been shown to correlate with the car-
diovascular organ injuries independently of the mean 
BP level 11,12）. Among the various time phases of BP 
variation, the diurnal changes have been most widely 
objective of many studies and a large amount of evi-
dence has been accumulated in implicatings for the 
risk of developing cardiovascular events and organ 
injuries. For example, the lack of nocturnal BP decline 
is defined as nondipper and is known to associate 
with the increased risk of cardiovascular events and 
organ injuries 13〜17）. The morning surge which is a 
prominent BP rise in the morning is thought to possi-
bly trigger the cardiovascular events such as 
stroke 18,19）. In addition, the patients with masked 
hypertension, which is defined as increased out-of-
office BP despite normal office BP, have been shown 
to likely to develop cardiovascular disorders, while the 
white-coat hypertension with increased office BP and 
normal out-of-office BP does not seem to add cardio-
vascular risk to the patients 20〜22）.
Much attention has been attracted to the report 
which showed positive association of visit-to-visit BP 
variation with the incidence of stroke in patients with 
transient ischemic attack 4）. The retrospective analysis 
of ASCOT-BPLA study, in which high-risk hyperten-
sive patients were treated with antihypertensive regi-
men with a CCB followed by the addition of an ACE 
inhibitor or a beta blocker followed by the addition of 
a diuretic, showed that the SD of systolic BP was 
smaller and the cardiovascular events were fewer in 
the CCB regimen than that in the beta blocker regi-
men 23）. On the other hand, the visit-to-visit BP varia-
tion was not a significant predictor of cardiovascular 
events in the post-hoc analysis of Syst-Eur study24）. 
Therefore, it seems that the implication of visit-to-vis-
it BP variation as to the risk of cardiovascular disor-
ders still remains a matter of controversy.
In the present study, the CV of office systolic BP 
was higher in the diabetic patients than that in the 
non-diabetic patients which may be related to the 
increased cardiovascular risk loaded by diabetes melli-
tus. Considering that the dysfunctions of baroreceptor 
reflex and autonomic nerve system are supposed to 
increase BP variability, the autonomic nerve impair-
ment due to diabetic neuropathy may have contribut-
ed to the exaggeration of BP variation. It has been 
indicated that the increased visit-to-visit BP variation 
is related to the renal dysfunction and cardiovascular 
organ injuries in diabetic patients 25〜27）.
In addition to the impaired nervous control of BP, 
the stiffening of arterial wall also augments the varia-
tion of BP. The patients with CVD showed greater 
variation of diastolic morning home BP than the 
patients without CVD in this study. It is speculated 
that the development of arteriosclerosis in CVD 
patients reduces the elasticity of arterial wall and aug-
ments the BP changes.
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In the patients with CKD, variations of diastolic 
off ice BP and diastol ic evening home BP were 
increased in addition to the increase in systolic eve-
ning home BP as compared with the patients without 
CKD. The reduction in renal function has been shown 
to affect diurnal BP changes and cause non-dipping 
pattern during night which is corrected by diuret-
ics 28）. The impaired regulation of urinary sodium 
excretion may increase the body fluid volume and BP 
changes especially during nighttime. In this context, it 
seems of interest that the day-to-day variations of 
morning and evening home BP showed significant 
correlations with the indices of renal function such as 
serum creatinine and eGFR. Namely, the home BP 
variation was increased with the reduction in renal 
function. It is speculated that the increased blood vol-
ume may have contributed to the increase in home 
systolic BP in CKD patients. On the other hand, the 
reduction in arterial elasticity may have contributed 
to the increased diastolic BP variability, because CKD 
patients are at high risk of developing cardiovascular 
diseases based on arteriosclerosis 29〜32）.
As to the effects of antihypertensive drug therapy 
on the BP variability, the meta-analysis of clinical 
studies has shown that CCBs have an advantage in 
reducing BP variation over other classes of antihyper-
tensive drugs 23,33〜36）. CCBs directly dilates arterioles 
and the action is not mediated by intrinsic factors 
regulating BP such as sodium retention status, sympa-
thetic nerve activity and renin-angiotensin-aldoste-
rone system, while the hypotensive effects of diuretics, 
b-blockers, ACE inhibitors and ARBs largely depend 
on these intrinsic factors. Therefore, CCBs are likely 
to exhibit constant BP reductions irrespective of the 
status of patients resulting in small BP variations. 
However, some studies have reported that ARBs have 
also reduced the visit-to-visit BP variations effectively 
in hypertensive patients 37）and in patients on renal 
replacement therapy 38,39）. Considering these, the com-
bination of CCB and ARB seems to be effective in 
reducing not only the BP level but also the variation 
of BP. And the addition of diuretic is expected to 
reduce BP variation derived from sodium retention 
especially in patients with impaired renal function.
In summary, this study examined the implications 
of visit-to-visit variation of office BP and day-to-day 
variation of home BP in hypertensive patients includ-
ing patients with diabetes mellitus, CKD and or CVD. 
The visit-to-visit variation of systolic office BP was 
increased in patients with diabetes mellitus. In CKD 
patients, visit-to-visit variation of diastolic office BP 
and day-to-day variation of diastolic evening home 
BP were increased as compared with non-CKD 
patients. The patients with CVD showed greater day-
to-day variation of diastolic morning home BP than 
the patients without CVD. Thus, It is indicated that 
such high-risk hypertensive patients show increased 
BP variability. In the management of hypertension, it 
may be desirable to reduce BP variations as well as 
BP levels in order to achieve effective prevention of 
cardiovascular diseases and organ injuries.
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